AXIOGENES Share Price

Stocks

End-of-day quote Xetra
- ^EUR	-

14/15/14	Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	BU
04/12/04	AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	BU
10/11/10	AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	BU

16/15/16

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.56%	-4.17%	-1.90%	+9.79%	4.56TCr
REVOLUTION MEDICINES, INC.	-0.01%	-1.06%	+343.99%	+545.86%	4.4TCr
IQVIA HOLDINGS INC.	+1.43%	+3.94%	+44.87%	+27.25%	4.37TCr
BEONE MEDICINES AG	-2.18%	-1.44%	+4.26%	+72.93%	4.02TCr
CELLTRION, INC.	-0.73%	-4.72%	+8.55%	+37.89%	3.19TCr
ASCENDIS PHARMA A/S	-9.44%	-11.13%	-	-	1.74TCr
MEDPACE HOLDINGS, INC.	+4.19%	+5.19%	+25.21%	+122.00%	1.66TCr
EUROFINS SCIENTIFIC SE	+1.83%	+2.63%	+15.14%	+33.31%	1.45TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.21%	-2.64%	+79.55%	+31.49%	1.3TCr
Average	-0.45%	-1.81%	+64.96%	+110.07%	2.97TCr
Weighted average by Cap.	-0.33%	-2.09%	+76.61%	+131.04%